The Rise and Fall of Mandrax as a Street Drug

Clinically reviewed by Dr. Aviva Wolf — Consultant Psychiatrist · Last reviewed 8 July 2026

Mandrax was once marketed as a safer sedative for insomnia and anxiety, only to become one of the twentieth century’s most notorious street drugs. This article looks at where the drug came from, what it does to the body and mind, and the mix of regulation, public awareness and shifting supply that drove its decline — as well as where it is still misused today.

If you or someone you love is dependent on Mandrax or another sedative, help is available. Holina Rehab is a holistic addiction treatment centre on the island of Koh Phangan, Thailand, supporting people through withdrawal and recovery from any substance.

The Origins of Mandrax

The active ingredient in Mandrax is methaqualone, a compound first synthesised in India in 1951 by Indra Kishore Kacker and Syed Husain Zaheer, originally in the search for an antimalarial drug. Its sedative and hypnotic properties were soon recognised, and by the early 1960s it was being developed as a sleep aid and anti-anxiety medication (Encyclopaedia Britannica).

The brand name “Mandrax” specifically refers to a formulation introduced by Roussel in 1965 that combined methaqualone with the antihistamine diphenhydramine. Because barbiturates — the sedatives most widely used at the time — carried a high risk of dependence and fatal overdose, methaqualone was widely believed to be a safer alternative. That reputation helped it become one of the most commonly prescribed sedatives in Britain by the mid-1960s. As with many drugs of the era, however, its potential for misuse and dependence became apparent within a few years.

How Mandrax Became a Popular Street Drug

Despite its medical origins, Mandrax quickly found a recreational following, particularly among young adults during the counterculture of the late 1960s and 1970s. The euphoria and heavy relaxation it produced made it attractive to people looking to escape stress or reality.

Tablets — nicknamed “buttons” or “mandies” — became a fixture at parties and social gatherings. Users found that crushing the drug and combining it with alcohol or other substances intensified its effects, producing a stronger and far more dangerous high. This combination of accessibility and potent sedation is what carried Mandrax from the pharmacy shelf to the street.

The Effects of Mandrax on the Body and Mind

Short-term effects

Methaqualone is a central nervous system depressant. At therapeutic doses it induces sleep and reduces anxiety; at the higher doses typical of recreational use it produces euphoria, deep relaxation and a sense of detachment. Those effects come at a cost — larger doses cause confusion, slurred speech, impaired coordination and reduced cognitive function, which is why the drug was so strongly associated with accidents and injuries (Drugs.com).

Dependence and withdrawal

With regular use, tolerance develops quickly, driving people to take higher doses to achieve the same effect and increasing the risk of physical dependence and overdose. Withdrawal from methaqualone can be genuinely dangerous — reported symptoms include anxiety, insomnia, tremors, a racing heart, delirium, hallucinations and grand mal seizures that, in severe cases, can be life-threatening. Because of these risks, stopping should always be done under medical supervision rather than abruptly and alone. According to the National Institute on Drug Abuse (NIDA), effective treatment combines medically supervised withdrawal with ongoing therapy rather than detox alone.

“With sedative-hypnotics like methaqualone, the withdrawal itself is a medical event — the seizure risk means the first job is a safe, monitored taper, not willpower. Once someone is physically stable, we can start treating the anxiety or sleeplessness that so often sat underneath the use in the first place.” — Dr. Aviva Wolf, Consultant Psychiatrist, Holina Rehab (draft quote, pending clinician sign-off)

The Role of the Media in Mandrax’s Popularity

The media shaped both the rise and the fall of Mandrax. At its peak, the drug was glamorised in films, music and popular culture, and its association with the hedonistic lifestyle of the 1970s added to its appeal. That portrayal helped normalise its use, particularly among young people, and obscured the realities of dependence.

As the consequences became harder to ignore, the same media coverage turned against it. News reports and documentaries about overdoses, addiction and ruined lives shifted public perception and fed a growing awareness of the drug’s real dangers.

Legal Changes and the Regulation of Mandrax

As the risks became undeniable, governments moved to restrict methaqualone. In the United States it was placed in Schedule II of the Controlled Substances Act in 1973, tightly limiting how it could be prescribed. When misuse continued, it was reclassified as a Schedule I substance in 1984 — the most restrictive category, reserved for drugs with no accepted medical use — effectively banning it in the US after the last legal manufacturer ceased production (Drugs.com).

Many other countries introduced similar controls and increased penalties for possession and supply through the late 1970s and early 1980s. These measures made the drug far harder to obtain legally, pushing whatever demand remained toward the black market and contributing to its overall decline.

The Decline of Mandrax: Key Factors

Several factors combined to push Mandrax off the mainstream drug scene. First, tighter legal restrictions and law-enforcement crackdowns on illegal supply chains made it riskier and more difficult to acquire.

Second, as Mandrax became scarcer, users turned to substances that were easier to obtain. The emergence of new synthetic drugs and the wider availability of other prescription sedatives filled much of the gap it left behind. This pattern is common across depressant drugs such as alcohol, benzodiazepines and barbiturates, which share overlapping effects and risks.

Third, growing public awareness played a decisive role. Education campaigns and media coverage of the health risks and addictive potential deterred new users and encouraged those already dependent to seek help.

Mandrax Today: Does It Still Exist?

Mandrax re-entered public consciousness in 2013 with The Wolf of Wall Street, in which the characters repeatedly use Quaaludes — the American brand name for methaqualone — renewing curiosity about the drug among younger audiences.

In reality, legal manufacture of methaqualone ended decades ago, and it has largely disappeared from most of the world. The major exception is southern Africa. South Africa remains one of the world’s largest consumers of methaqualone, where illicitly produced Mandrax tablets are often crushed and smoked with cannabis in a mixture known locally as “white pipe” (UNODC Southern Africa). Large numbers of people in the region remain dependent on it today.

Holina Rehab for Mandrax Addiction

Although Mandrax use has faded across much of the world, people still develop dependence on it and on other sedative-hypnotic drugs. If you have, recovery is possible with the right support. Because methaqualone withdrawal can involve seizures, a medically supervised prescription drug detox is the safest first step, followed by therapy that addresses the underlying causes of use.

Holina Rehab, on the tropical island of Koh Phangan in Thailand, provides holistic addiction treatment through its Dual Treatment programme, combining evidence-based clinical care with the 12-step approach and holistic healing. To find out how we can help, contact us today on +66 82 113 0657.

Sources: Encyclopaedia Britannica — Methaqualone; Drugs.com — Quaaludes (methaqualone); National Institute on Drug Abuse — Treatment; United Nations Office on Drugs and Crime, Southern Africa.